Evidence map›Paper›PMID 29851503›Full record

ArticleAIDS patient care and STDs2018

Metabolic Syndrome Among Antiretroviral Therapy-Naive Versus Experienced HIV-Infected Patients Without Preexisting Cardiometabolic Disorders in Western Kenya.

Alfred Osoti, Tecla M Temu, Nicholas Kirui, Edmond K Ngetich, Jemima H Kamano, Stephanie Page, Carey Farquhar, Gerald S Bloomfield

Open access · greenAbstract readComparative Study
In one paragraph

Article in AIDS patient care and STDs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 7 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 7 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Alfred Osoti1 Department of Obstetrics and Gynecology, University of Nairobi , Nairobi, Kenya .
Tecla M Temu2 Department of Global Health, University of Washington , Seattle, Washington.
Nicholas Kirui4 Division of Medicine, Moi Teaching and Referral Hospital , Eldoret, Kenya .
Edmond K Ngetich5 AMPATH Partnership , Eldoret, Kenya .
Jemima H Kamano4 Division of Medicine, Moi Teaching and Referral Hospital , Eldoret, Kenya .
Stephanie Page7 Department of Medicine, University of Washington , Seattle, Washington.
Carey Farquhar2 Department of Global Health, University of Washington , Seattle, Washington.
Gerald S Bloomfield8 Department of Medicine, Duke Clinical Research Institute and Duke Global Health Institute, Duke University , Durham, North Carolina.
University of Washington · USAMPATH · KEDuke Institute for Health Innovation · USMoi University · KEUniversity of Nairobi · KE

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI REBECCA LUCY HULL-MEICHLE · 1986 to 2026
$41.4M
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)R25TW009337 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HEIMBURGER, DOUGLAS CORBETT, VERMUND, STEN H. · 2012 to 2016
$6.3M
Promoting Diversity, Equity, and Inclusivity in Research Training to Optimize HIV Prevention and TreatmentD43TW009580 · FIC · UNIVERSITY OF WASHINGTON · PI CAREY FARQUHAR, John Kinuthia · 2013 to 2026
$4.8M
Gestational diabetes mellitus, gestational hypertension and risk of metabolic syndromeK43TW010363 · FIC · UNIVERSITY OF NAIROBI · PI OSOTI, ALFRED ONYANGO · 2016 to 2020
$566k
Predicting Early Cardiovascular Risk among HIV-Infected and Uninfected Kenyan AdultsR21TW010459 · FIC · UNIVERSITY OF WASHINGTON · PI FARQUHAR, CAREY, PAGE, STEPHANIE T · 2016 to 2017
$463k
FIC NIH HHS D43 TW009580FIC NIH HHS K43 TW010363FIC NIH HHS R21 TW010459FIC NIH HHS R25 TW009337NHLBI NIH HHS HHSN268200900031CNIDDK NIH HHS P30 DK017047PEPFAR
6 · The paper itself

Abstract

Metabolic syndrome (MetS), a cluster of cardiovascular disease risk factors, is increasingly common in people living with HIV; however, data on prevalence and the role of antiretroviral therapy (ART) as a risk factor for MetS in sub-Saharan Africa are lacking. We conducted a cross-sectional study to assess the prevalence and risk factors for MetS among ART-naive and ART-experienced HIV-infected adults without preexisting cardiometabolic disorders in Western Kenya using validated questionnaires and laboratory tests after overnight fasting. We used logistic regression to identify associations between traditional risk factors, HIV disease characteristics, ART, and MetS. Study participants included 164 ART-experienced patients, majority (56%) on tenofovir/lamivudine/nevirapine regimen, and 136 ART-naive patients. The median age was 40 (interquartile range, 33-46) years and 64% were women. Median HIV infection and ART use were 4.6 (1.7-7.9) and 4.8 (2.7-7.8) years, respectively. Prevalence of MetS did not differ between ART-experienced (16.9%) and -naive (15.2%) groups. ART-experienced patients had higher rates of elevated fasting blood sugars and lower rates of low high-density lipoprotein-cholesterol. The prevalence of abnormal waist circumference, elevated blood pressure, and hypertriglyceridemia were comparable between the two groups. Older age, female sex, and high body mass index were independently associated with diagnosis of MetS. Traditional risk factors rather than ART-related effects were more important predictors of MetS in this cohort and may have been influenced by ART type and exclusion of preexisting hypertension and diabetes. HIV-infected patients without preexisting cardiometabolic disorders should be monitored for metabolic abnormalities regardless of ART.

Indexed as

AdultAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveBody Mass IndexCardiovascular DiseasesCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleHIV InfectionsHumansHypertensionKenyaMaleMetabolic SyndromeMiddle AgedPrevalenceAnti-HIV Agentsantiretroviral therapycardiovascular diseasesHIVKenyametabolic syndromesub-Saharan Africa

Identifiers

PMID29851503
PMCPMC5982154
OpenAlexW2807405530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.